Worldwide siRNA technology market estimated to reach $60 million in 2004
(PRWEB) August 26, 2004
Research and Markets announces the addition of siRNA 2004: A Strategic Market Outlook and Business Analysis to its offerings.
Small interfering RNA (siRNA) technology has the potential to completely revolutionize the drug discovery process. A breakthrough in biotechnology, siRNA technology has potent and rapid gene silencing properties that have led to its rapid adoption by the scientific community. Within the drug discovery process, many researchers currently use siRNAin small scale experiments, but as the technology improves andintegrates with high-throughput innovation, high-content functional genomic screens will be possible.
The worldwide siRNAtechnology market is estimated to reach $60 million in 2004 andwill likely experience high annual growth as the full potential of the technology is realized. By 2009, the market is projected to more than quadruple in size, with healthy market demand and the resolution of patent issues.
The existing siRNA technology market is dominated by four industry players-Ambion, Dharmacon, Proligo and QIAGEN-with licenses to one of the key patents in the field. The market for siRNA reagent technology will be greatly impacted by the resolution of patent disputes over currently commercialized technology.
This report includes an in-depth analysis of researcher and management perspectives, company profiles, and a assessment of the trends, challenges, and strategic options facing reagent supply firms operating in the siRNAtechnology space. In addition, the study provides the financial analysis and detailed assumptions used to determine major company market shares and to estimate the industry-wide revenue forecast.
For a comprehensive analysis of this market, this report:
evaluates leading current and emerging siRNAtechnologies assesses the results of 15 thought leader interviews and examines their views on market trends, limitations, and developments provides a worldwide market forecast and revenue model from 2004 through 2009 with detailed assumptions for each technology profiles and analyzes the strategic positioning of 7 established market players identifies multiple market challenges provides strategic options for siRNAtechnology companies looking to expand revenues
For a complete index of this report click on http://www. researchandmarkets. com/reports/222267 (http://www. researchandmarkets. com/reports/222267)
About Research and Markets Ltd.
Research and Markets Ltd. are Europe's largest resource for market research. R&M distribute thousands of major research publications from the world's leading publishers, consultants and market analysts. R&M provide you with the latest forecasts on international and regional markets, key industries, the top companies, new products and the latest market trends.
For additional information on ResearchandMarkets. com, their range of reports or their value-added services, visit their web site at http://www. researchandmarkets. com (http://www. researchandmarkets. com) or mailto:press@researchandmarkets. com
